Abstract:Introduction: Forkhead (FOX) transcription factors are involved in cell cycle control, cellular differentiation, maintenance of tissues, and aging. Mutation or aberrant expression of FOX proteins is associated with developmental disorders and cancers. FOXM1, an oncogenic transcription factor, is a promoter of cell proliferation and accelerated development of breast adenocarcinomas, squamous carcinoma of the head, neck, and cervix, and nasopharyngeal carcinoma. High FOXM1 expression is correlated with chemoresistance in patients treated with doxorubicin and Epirubicin by enhancing the DNA repair in breast cancer cells. Method: miRNA-seq identified downregulation of miR-4521 in breast cancer cell lines. Stable miR-4521 overexpressing breast cancer cell lines (MCF-7, MDA-MB-468) were developed to identify miR-4521 target gene and function in breast cancer. Results: Here, we showed that FOXM1 is a direct target of miR-4521 in breast cancer. Overexpression of miR-4521 significantly downregulated FOXM1 expression in breast cancer cells. FOXM1 regulates cell cycle progression and DNA damage response in breast cancer. We showed that miR-4521 expression leads to increased ROS levels and DNA damage in breast cancer cells. FOXM1 plays a critical role in ROS scavenging and promotes stemness which contributes to drug resistance in breast cancer. We observed that breast cancer cells stably expressing miR-4521 lead to cell cycle arrest, impaired FOXM1 mediated DNA damage response leading to increased cell death in breast cancer cells. Additionally, miR-4521-mediated FOXM1 downregulation perturbs cell proliferation, invasion, cell cycle progression, and epithelial-to-mesenchymal progression (EMT) in breast cancer. Discussion: High FOXM1 expression has been associated with radio and chemoresistance contributing to poor patient survival in multiple cancers, including breast cancer. Our study showed that FOXM1 mediated DNA damage response could be targeted using miR-4521 mimics as a novel therapeutic for breast cancer.

High impact of miRNA-4521 on FOXM1 expression in medulloblastoma

MiR-4521 perturbs FOXM1-mediated DNA damage response in breast cancer

Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2

miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4

miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression

CircSKA3 Modulates FOXM1 to Facilitate Cell Proliferation, Migration, and Invasion While Confine Apoptosis in Medulloblastoma Via Mir-383-5p

Inhibition of FOXM1 by Thiostrepton Sensitizes Medulloblastoma to the Effects of Chemotherapy.

Comprehensive Analysis of a Microrna Expression Profile in Pediatric Medulloblastoma.

Microrna-451 Inhibits Neuroblastoma Proliferation, Invasion and Migration by Targeting Macrophage Migration Inhibitory Factor

MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma

MiRNA-451 plays a role as tumor suppressor in human glioma cells.

The Tumor Suppressive Role of Mirna-370 by Targeting FoxM1 in Acute Myeloid Leukemia.

FOXO1/miR-506/ETS1 Feedback Loop Promotes Chemosensitivity to Temozolomide and Suppresses Invasiveness in Glioblastoma

Mir-216B Inhibits Glioma Cell Migration and Invasion Through Suppression of FoxM1

MicroRNA-564 is Downregulated in Glioblastoma and Inhibited Proliferation and Invasion of Glioblastoma Cells by Targeting TGF-β1.

MicroRNA-338-5p Plays a Tumor Suppressor Role in Glioma Through Inhibition of the MAPK-signaling Pathway by Binding to FOXD1

MiR-542-3p suppresses neuroblastoma cell proliferation and invasion by downregulation of KDM1A and ZNF346

microRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1

Medulloblastoma Malignant Biological Behaviors Are Associated with HOTAIR/miR-483-3p/CDK4 Axis

microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.

Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma